Patton Albertson Miller Group, LLC Biogen Inc. Transaction History

Patton Albertson Miller Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $281,129 - $309,885	-1,282 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $225,595 - $352,857	-1,041 Reduced 44.81%	1,282 $303,000
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $545,303 - $690,684	-1,958 Reduced 45.74%	2,323 $736,000
Q3 2018 Oct 25, 2018	SELL	$293.51 - $383.83 $50,483 - $66,018	-172 Reduced 3.86%	4,281 $1.29 Million
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $44,293 - $52,788	172 Added 4.02%	4,453 $1.29 Million
Q1 2018 May 01, 2018	BUY	$260.13 - $367.91 $81,680 - $115,523	314 Added 7.92%	4,281 $1.17 Million
Q4 2017 Feb 02, 2018	BUY	$307.64 - $344.58 $26,149 - $29,289	85 Added 2.19%	3,967 $1.26 Million
Q3 2017 Oct 06, 2017	BUY	$281.15 - $329.69 $1.09 Million - $1.28 Million	3,882	3,882 $1.27 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Patton Albertson Miller Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Patton Albertson Miller Group, LLC with notifications on news.